Topic

medtech

The image features a banner showcasing Qure.ai. On the left side, the Qure.ai logo is prominently displayed against an orange background. In the center, Prashant Warier, cofounder and CEO of Qure.ai, is seated, smiling confidently. To the right, there is a depiction of Qure.ai’s AI-powered medical diagnostic platform, displaying a patient’s medical imaging results, including a detailed view of a CT scan highlighting a lung nodule. The interface of the diagnostic tool is visible on a smartphone and desktop screen, illustrating its advanced medical imaging capabilities.

Qure Secures $65 Million Investment to Develop AI-Driven Disease Detection Products

Medtech startup Qure.ai has secured $65 million in Series D funding, co-led by Lightspeed Venture Partners and 360 ONE Asset Management. The funds will be used for expanding into new markets, improving AI models, and supporting acquisitions. Founded by Prashant Warier in 2016, Qure.ai leverages AI for rapid diagnostics in medical imaging, detecting conditions like brain trauma and chest diseases. With AI playing an increasing role in healthcare, India’s medtech sector is evolving through digital health innovations, AI integration, and wearable technology advancements.